Business Segments · Additions and adjustments

Orthopaedics and Spine — Additions and adjustments

Stryker Orthopaedics and Spine — Additions and adjustments remained flat by 0.0% to $75.00M in Q4 2024 compared to the prior quarter. Over 3 years (FY 2021 to FY 2024), Orthopaedics and Spine — Additions and adjustments shows an upward trend with a 72.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalLower is better
VolatilityVolatile
First reportedQ1 2020
Last reportedQ4 2024

How to read this metric

An increase suggests higher non-recurring costs or accounting adjustments, while a decrease indicates fewer extraordinary charges impacting the segment.

Detailed definition

Represents non-recurring or non-operational financial adjustments specifically allocated to the Orthopaedics business se...

Peer comparison

Similar to 'special items' or 'restructuring charges' found in the segment reporting of other medical device manufacturers.

Metric ID: syk_segment_orthopaedics_additions_and_adjustments

Historical Data

4 years
 FY'21FY'22FY'23FY'24
Value$59.00M$0.00$0.00$300.00M
YoY Change-100.0%
Range$0.00$300.00M
CAGR+72.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Stryker's orthopaedics and spine — additions and adjustments?
Stryker (SYK) reported orthopaedics and spine — additions and adjustments of $75.00M in Q4 2024.
What is the long-term trend for Stryker's orthopaedics and spine — additions and adjustments?
Over 3 years (2021 to 2024), Stryker's orthopaedics and spine — additions and adjustments has grown at a 72.0% compound annual growth rate (CAGR), from $59.00M to $300.00M.
What does orthopaedics and spine — additions and adjustments mean?
One-time or non-operational financial adjustments impacting the Orthopaedics segment's reported results.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.